Innovative Pharmaceutical Biotech Limited (0399.HK)
HKD 0.17
(4.85%)
HKD 0.17
(4.85%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.38 Billion HKD | -0.07% |
| 2022 | 1.38 Billion HKD | -0.78% |
| 2021 | 1.39 Billion HKD | -0.59% |
| 2020 | 1.4 Billion HKD | -1.1% |
| 2019 | 1.41 Billion HKD | -10.13% |
| 2018 | 1.57 Billion HKD | -7.9% |
| 2017 | 1.71 Billion HKD | -7.39% |
| 2016 | 1.85 Billion HKD | -7.92% |
| 2015 | 2.01 Billion HKD | -1.49% |
| 2014 | 2.04 Billion HKD | 175.19% |
| 2013 | 741.51 Million HKD | 45.96% |
| 2012 | 508.03 Million HKD | 42.71% |
| 2011 | 355.99 Million HKD | -23.81% |
| 2010 | 467.25 Million HKD | -11.28% |
| 2009 | 526.68 Million HKD | 275.56% |
| 2008 | 140.23 Million HKD | 162.06% |
| 2007 | 53.51 Million HKD | 3.53% |
| 2006 | 51.69 Million HKD | 8.04% |
| 2005 | 47.84 Million HKD | -1.1% |
| 2004 | 48.37 Million HKD | -74.89% |
| 2003 | 192.64 Million HKD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | 1.38 Billion HKD | 0.0% |
| 2023 Q1 | 1.38 Billion HKD | -0.13% |
| 2023 FY | 1.38 Billion HKD | -0.07% |
| 2023 Q4 | 1.38 Billion HKD | 0.0% |
| 2023 Q3 | 1.38 Billion HKD | 0.06% |
| 2022 FY | 1.38 Billion HKD | -0.78% |
| 2022 Q3 | 1.38 Billion HKD | -0.53% |
| 2022 Q4 | 1.38 Billion HKD | 0.0% |
| 2022 Q2 | 1.39 Billion HKD | 0.0% |
| 2022 Q1 | 1.39 Billion HKD | -0.26% |
| 2021 Q1 | 1.4 Billion HKD | -0.19% |
| 2021 Q2 | 1.4 Billion HKD | 0.0% |
| 2021 Q3 | 1.39 Billion HKD | -0.39% |
| 2021 Q4 | 1.39 Billion HKD | 0.0% |
| 2021 FY | 1.39 Billion HKD | -0.59% |
| 2020 FY | 1.4 Billion HKD | -1.1% |
| 2020 Q4 | 1.4 Billion HKD | 0.0% |
| 2020 Q2 | 1.4 Billion HKD | 0.0% |
| 2020 Q3 | 1.4 Billion HKD | -0.09% |
| 2020 Q1 | 1.4 Billion HKD | -1.02% |
| 2019 Q4 | 1.41 Billion HKD | 0.0% |
| 2019 Q2 | 1.58 Billion HKD | 0.0% |
| 2019 FY | 1.41 Billion HKD | -10.13% |
| 2019 Q1 | 1.58 Billion HKD | 0.36% |
| 2019 Q3 | 1.41 Billion HKD | -10.45% |
| 2018 Q2 | 1.6 Billion HKD | 0.0% |
| 2018 Q3 | 1.57 Billion HKD | -1.8% |
| 2018 Q4 | 1.57 Billion HKD | 0.0% |
| 2018 FY | 1.57 Billion HKD | -7.9% |
| 2018 Q1 | 1.6 Billion HKD | -6.21% |
| 2017 Q4 | 1.71 Billion HKD | 0.0% |
| 2017 Q3 | 1.71 Billion HKD | -1.29% |
| 2017 Q2 | 1.73 Billion HKD | 0.0% |
| 2017 Q1 | 1.73 Billion HKD | -6.18% |
| 2017 FY | 1.71 Billion HKD | -7.39% |
| 2016 Q3 | 1.85 Billion HKD | -3.08% |
| 2016 Q4 | 1.85 Billion HKD | 0.0% |
| 2016 Q1 | 1.9 Billion HKD | -4.99% |
| 2016 FY | 1.85 Billion HKD | -7.92% |
| 2016 Q2 | 1.9 Billion HKD | 0.0% |
| 2015 Q2 | 2.07 Billion HKD | 0.0% |
| 2015 Q3 | 2.01 Billion HKD | -3.34% |
| 2015 Q4 | 2.01 Billion HKD | 0.0% |
| 2015 Q1 | 2.07 Billion HKD | 1.91% |
| 2015 FY | 2.01 Billion HKD | -1.49% |
| 2014 Q3 | 2.04 Billion HKD | 0.11% |
| 2014 FY | 2.04 Billion HKD | 175.19% |
| 2014 Q1 | 2.03 Billion HKD | 174.88% |
| 2014 Q4 | 2.04 Billion HKD | 0.0% |
| 2014 Q2 | 2.03 Billion HKD | 0.0% |
| 2013 Q3 | 832.98 Million HKD | 0.0% |
| 2013 Q4 | 741.51 Million HKD | -10.98% |
| 2013 FY | 741.51 Million HKD | 45.96% |
| 2013 Q1 | 508.03 Million HKD | 0.0% |
| 2013 Q2 | 832.98 Million HKD | 63.96% |
| 2012 FY | 508.03 Million HKD | 42.71% |
| 2012 Q2 | 419.79 Million HKD | 17.92% |
| 2012 Q1 | 355.99 Million HKD | 0.0% |
| 2012 Q3 | 419.79 Million HKD | 0.0% |
| 2012 Q4 | 508.03 Million HKD | 21.02% |
| 2011 FY | 355.99 Million HKD | -23.81% |
| 2011 Q3 | 445.04 Million HKD | 0.0% |
| 2011 Q1 | 467.25 Million HKD | 0.0% |
| 2010 Q3 | 477.42 Million HKD | 0.0% |
| 2010 Q1 | 526.68 Million HKD | 0.0% |
| 2010 FY | 467.25 Million HKD | -11.28% |
| 2009 FY | 526.68 Million HKD | 275.56% |
| 2008 FY | 140.23 Million HKD | 162.06% |
| 2007 FY | 53.51 Million HKD | 3.53% |
| 2006 FY | 51.69 Million HKD | 8.04% |
| 2005 FY | 47.84 Million HKD | -1.1% |
| 2004 FY | 48.37 Million HKD | -74.89% |
| 2003 FY | 192.64 Million HKD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 882.58 Million HKD | -56.702% |
| China Overseas Nuoxin International Holdings Limited | 149.17 Million HKD | -827.09% |
| Prosperous Future Holdings Limited | 810.79 Million HKD | -70.577% |
| Huasheng International Holding Limited | 1.63 Billion HKD | 15.462% |
| Fourace Industries Group Holdings Limited | 475.91 Million HKD | -190.602% |
| Evergreen Products Group Limited | 1.63 Billion HKD | 15.233% |
| EC Healthcare | 5.37 Billion HKD | 74.26% |
| Ming Fai International Holdings Limited | 1.96 Billion HKD | 29.625% |
| Blue Moon Group Holdings Limited | 12.05 Billion HKD | 88.525% |
| SuperRobotics Holdings Limited | 27.55 Million HKD | -4919.318% |
| Takbo Group Holdings Limited | 279.77 Million HKD | -394.336% |
| Hyfusin Group Holdings Limited | 686.91 Million HKD | -101.337% |